ZyCoV-D shot can remain stable at room temperature: Zydus Cadila chairman
The company plans to apply for approval once it finishes phase 3 trials12-12-2020
12-12-2020
Zydus gets Fast Track Designation' by USFDA for Saroglitazar
Pharma major Cadila Healthcare Limited on Wednesday announced that the company has received an approval from the US Food and Drug Administration (09-12-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus granted Fast Track Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)09-12-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting dated December 8, 2020 with regard to loss of share certificate of the Company published in Financial Express09-12-2020
Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1
In a regulatory filing, Zydus Cadila said "it has received permission to initiate the phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate. NLRP3 inflammasomes are involved in the inflammation process".07-12-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus announces Phase I trials of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor07-12-2020
Zydus gets DCGI approval for phase-3 clinical trials of Covid-19 therapy
Trials will involve use of Cadila's biological therapy Pegylated Interferon alpha-2b in India04-12-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India04-12-2020
CADILA HEALTHCARE LTD. - 532321 - Consolidated Related Party Transactions
Consolidated Related Party Transactions30-11-2020
PM Modi's presence to motivate company in quest to bridge unmet healthcare needs: Zydus Cadila
PM Modi visited Zydus Cadila's manufacturing facility near Ahmedabad, as he began his three-city visit to review ongoing coronavirus vaccine development work.28-11-2020